Showing 1 - 20 results of 4,902 for search '(( can lead decrease ) OR ( a ((large decrease) OR (marked decrease)) ))', query time: 0.41s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer by Ben J. Haines (22458462)

    Published 2025
    “…Papaverine is typically used as a vasorelaxant due to its ability to inhibit phosphodiesterase 10A (PDE10A), which can lead to unwanted side effects when used clinically as a radiosensitizer. …”
  12. 12

    Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer by Ben J. Haines (22458462)

    Published 2025
    “…Papaverine is typically used as a vasorelaxant due to its ability to inhibit phosphodiesterase 10A (PDE10A), which can lead to unwanted side effects when used clinically as a radiosensitizer. …”
  13. 13
  14. 14
  15. 15

    Table 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

    Published 2025
    “…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …”
  16. 16

    Table 2_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

    Published 2025
    “…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …”
  17. 17

    Table 3_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

    Published 2025
    “…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …”
  18. 18

    Table 5_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

    Published 2025
    “…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …”
  19. 19

    Table 4_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

    Published 2025
    “…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …”
  20. 20

    Image 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.tif by Fengwang Xue (22245625)

    Published 2025
    “…Background<p>Long-term or high-dose glucocorticoid administration can markedly impair immune responses, mask clinical indicators of pulmonary infections, and increase the susceptibility to refractory pneumonia, leading to heightened mortality risk. …”